Summary of Conference Call for Morning Light Bio (晨光生物) Industry Overview - The industry is currently at an absolute bottom, with prices for chili red and chili extract at near 10-20 year lows, and lutein profit margins at historical lows, indicating limited downside potential. A cyclical reversal is expected in the second half of 2026 [2][3] - Supply-demand dynamics are shifting towards a tight balance, with a significant decline in raw material planting areas expected in 2025, leading to gradual inventory digestion. If planting further decreases in 2026, a supply gap may trigger a nonlinear price rebound [2][4] Company Performance and Strategy - Customized business is expanding significantly, with the proportion of customized chili red sales expected to rise to nearly 20% in 2025 from 5% in 2023. The price and gross margin of food-grade lutein are significantly higher than feed-grade, enhancing customer stickiness and pricing power [2][4] - Product category expansion supports growth, with sales of stevia glycosides projected to reach 280 million yuan in 2025, a tenfold increase over five years. The company is also expanding into monk fruit, Sichuan pepper extract, and health product ODM, with health product capacity expected to support a scale of 200 million yuan in 2026 [2][4] - The cottonseed business is optimizing its structure by reducing trade ratios and concentrating core production capacity in cost-effective Xinjiang, with the high-value 60 protein ratio expected to rise to 60%-80% [2][4] Financial Projections - R&D expense ratio is expected to decline as customized projects conclude, product prices stabilize, and cottonseed trade reduces, with a forecasted return to stability in 2026 [3][6] - The company anticipates that the overall R&D expense ratio will decrease in 2026 and remain stable in the following years, aligning with business growth [6][7] Market Dynamics - The cottonseed market has seen price fluctuations due to international trade tensions and commodity price increases, with a return to normal levels expected after initial irrational price spikes [8][9] - The company has shifted its chili extract raw material sourcing entirely to Yunnan, eliminating purchases from Xinjiang since 2025, which has affected product pricing and market strategy [10][11] Future Outlook - The company is focusing on stabilizing planting areas for lutein in 2026, with expectations of a tight supply-demand balance. Price adjustments are anticipated to be influenced by supply conditions rather than direct market inquiries [12] - The company aims to enhance its capabilities in product customization and downstream applications, with plans to gradually build its own brand in health products while prioritizing ODM business in the short term [7][8] Key Takeaways - The industry is at a low point, with potential for recovery in 2026 due to supply constraints - The company is expanding its customized product offerings and optimizing its cottonseed business - Financial metrics indicate a potential decline in R&D expenses as the business stabilizes - Strategic shifts in sourcing and product development are aimed at enhancing market competitiveness and customer relationships